ClinicalTrials.Veeva

Menu
P

Pratia | Klinische Forschung Dresden

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Brenipatide
LY3502970
Orforglipron
Semaglutide
Alcohol
Muvalaplin

Parent organization

This site is a part of Pratia

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study of Brenipatide in Participants With Alcohol Use Disorder (RENEW-ALC-2)

The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and...

Begins enrollment this month
Alcohol Use Disorder
Drug: Placebo
Drug: LY3537031

The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use...

Begins enrollment this month
Alcohol Use Disorder
Drug: LY3537031
Drug: Placebo
Locations recently updated

The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron work...

Enrolling
Osteoarthritis
Drug: Orforglipron
Drug: Placebo
Locations recently updated

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Placebo
Drug: Muvalaplin

Trial sponsors

Lilly logo
Novo Nordisk logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems